48,520 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by BSN CAPITAL PARTNERS Ltd

BSN CAPITAL PARTNERS Ltd bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 48,520 shares of the healthcare conglomerate’s stock, valued at approximately $28,369,000. UnitedHealth Group makes up about 5.4% of BSN CAPITAL PARTNERS Ltd’s holdings, making the stock its 2nd biggest position.

A number of other institutional investors also recently made changes to their positions in the business. Visionary Wealth Advisors lifted its position in UnitedHealth Group by 3.2% in the fourth quarter. Visionary Wealth Advisors now owns 1,232 shares of the healthcare conglomerate’s stock valued at $649,000 after purchasing an additional 38 shares during the last quarter. Garner Asset Management Corp bought a new stake in UnitedHealth Group during the 4th quarter valued at $132,000. True Wealth Design LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at about $31,000. Waverly Advisors LLC boosted its holdings in shares of UnitedHealth Group by 90.8% during the fourth quarter. Waverly Advisors LLC now owns 9,710 shares of the healthcare conglomerate’s stock worth $5,112,000 after purchasing an additional 4,622 shares during the period. Finally, Pinnacle Holdings LLC increased its holdings in UnitedHealth Group by 1.0% during the 4th quarter. Pinnacle Holdings LLC now owns 10,503 shares of the healthcare conglomerate’s stock valued at $5,530,000 after purchasing an additional 99 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.7 %

Shares of UNH stock opened at $591.22 on Thursday. The firm has a fifty day moving average price of $582.98 and a 200-day moving average price of $529.56. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The company has a market cap of $545.94 billion, a price-to-earnings ratio of 36.14, a PEG ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.14 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 51.34%.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently commented on UNH. Truist Financial raised their price target on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Argus raised their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.